Tuesday, July 04, 2017 11:35:21 AM
This means the medicinal cannabis company’s shares have jumped over 20% since this time last week.
Why has it jumped?
The rally in AusCann’s shares can be traced back to June 15 when the company announced the key appointment of Dr Danial Schecter as Chief Medical Advisor.
Since the day of this announcement, AusCann’s shares have climbed in excess of 30%.
Investors appear to be optimistic that the appointment of the international medical cannabis expert will help the company succeed in its medical outreach program.
The company aims for the program to educate Australian physicians about the benefits of medicinal cannabis, ultimately allowing them to make an informed decision on whether or how to prescribe cannabinoid medicines.
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM